skip to main content

Title: PointContrast: Unsupervised Pre-training for 3D Point Cloud Understanding
Arguably one of the top success stories of deep learning is transfer learning. The finding that pre-training a network on a rich source set (e.g., ImageNet) can help boost performance once fine-tuned on a usually much smaller target set, has been instrumental to many applications in language and vision. Yet, very little is known about its usefulness in 3D point cloud understanding. We see this as an opportunity considering the effort required for annotating data in 3D. In this work, we aim at facilitating research on 3D representation learning. Different from previous works, we focus on high-level scene understanding tasks. To this end, we select a suit of diverse datasets and tasks to measure the effect of unsupervised pre-training on a large source set of 3D scenes. Our findings are extremely encouraging: using a unified triplet of architecture, source dataset, and contrastive loss for pre-training, we achieve improvement over recent best results in segmentation and detection across 6 different benchmarks for indoor and outdoor, real and synthetic datasets – demonstrating that the learned representation can generalize across domains. Furthermore, the improvement was similar to supervised pre-training, suggesting that future efforts should favor scaling data collection over more detailed annotation. We more » hope these findings will encourage more research on unsupervised pretext task design for 3D deep learning. « less
Authors:
; ; ; ; ;
Award ID(s):
1763268
Publication Date:
NSF-PAR ID:
10285230
Journal Name:
European Conference on Computer Vision
Sponsoring Org:
National Science Foundation
More Like this
  1. Obeid, I. (Ed.)
    The Neural Engineering Data Consortium (NEDC) is developing the Temple University Digital Pathology Corpus (TUDP), an open source database of high-resolution images from scanned pathology samples [1], as part of its National Science Foundation-funded Major Research Instrumentation grant titled “MRI: High Performance Digital Pathology Using Big Data and Machine Learning” [2]. The long-term goal of this project is to release one million images. We have currently scanned over 100,000 images and are in the process of annotating breast tissue data for our first official corpus release, v1.0.0. This release contains 3,505 annotated images of breast tissue including 74 patients withmore »cancerous diagnoses (out of a total of 296 patients). In this poster, we will present an analysis of this corpus and discuss the challenges we have faced in efficiently producing high quality annotations of breast tissue. It is well known that state of the art algorithms in machine learning require vast amounts of data. Fields such as speech recognition [3], image recognition [4] and text processing [5] are able to deliver impressive performance with complex deep learning models because they have developed large corpora to support training of extremely high-dimensional models (e.g., billions of parameters). Other fields that do not have access to such data resources must rely on techniques in which existing models can be adapted to new datasets [6]. A preliminary version of this breast corpus release was tested in a pilot study using a baseline machine learning system, ResNet18 [7], that leverages several open-source Python tools. The pilot corpus was divided into three sets: train, development, and evaluation. Portions of these slides were manually annotated [1] using the nine labels in Table 1 [8] to identify five to ten examples of pathological features on each slide. Not every pathological feature is annotated, meaning excluded areas can include focuses particular to these labels that are not used for training. A summary of the number of patches within each label is given in Table 2. To maintain a balanced training set, 1,000 patches of each label were used to train the machine learning model. Throughout all sets, only annotated patches were involved in model development. The performance of this model in identifying all the patches in the evaluation set can be seen in the confusion matrix of classification accuracy in Table 3. The highest performing labels were background, 97% correct identification, and artifact, 76% correct identification. A correlation exists between labels with more than 6,000 development patches and accurate performance on the evaluation set. Additionally, these results indicated a need to further refine the annotation of invasive ductal carcinoma (“indc”), inflammation (“infl”), nonneoplastic features (“nneo”), normal (“norm”) and suspicious (“susp”). This pilot experiment motivated changes to the corpus that will be discussed in detail in this poster presentation. To increase the accuracy of the machine learning model, we modified how we addressed underperforming labels. One common source of error arose with how non-background labels were converted into patches. Large areas of background within other labels were isolated within a patch resulting in connective tissue misrepresenting a non-background label. In response, the annotation overlay margins were revised to exclude benign connective tissue in non-background labels. Corresponding patient reports and supporting immunohistochemical stains further guided annotation reviews. The microscopic diagnoses given by the primary pathologist in these reports detail the pathological findings within each tissue site, but not within each specific slide. The microscopic diagnoses informed revisions specifically targeting annotated regions classified as cancerous, ensuring that the labels “indc” and “dcis” were used only in situations where a micropathologist diagnosed it as such. Further differentiation of cancerous and precancerous labels, as well as the location of their focus on a slide, could be accomplished with supplemental immunohistochemically (IHC) stained slides. When distinguishing whether a focus is a nonneoplastic feature versus a cancerous growth, pathologists employ antigen targeting stains to the tissue in question to confirm the diagnosis. For example, a nonneoplastic feature of usual ductal hyperplasia will display diffuse staining for cytokeratin 5 (CK5) and no diffuse staining for estrogen receptor (ER), while a cancerous growth of ductal carcinoma in situ will have negative or focally positive staining for CK5 and diffuse staining for ER [9]. Many tissue samples contain cancerous and non-cancerous features with morphological overlaps that cause variability between annotators. The informative fields IHC slides provide could play an integral role in machine model pathology diagnostics. Following the revisions made on all the annotations, a second experiment was run using ResNet18. Compared to the pilot study, an increase of model prediction accuracy was seen for the labels indc, infl, nneo, norm, and null. This increase is correlated with an increase in annotated area and annotation accuracy. Model performance in identifying the suspicious label decreased by 25% due to the decrease of 57% in the total annotated area described by this label. A summary of the model performance is given in Table 4, which shows the new prediction accuracy and the absolute change in error rate compared to Table 3. The breast tissue subset we are developing includes 3,505 annotated breast pathology slides from 296 patients. The average size of a scanned SVS file is 363 MB. The annotations are stored in an XML format. A CSV version of the annotation file is also available which provides a flat, or simple, annotation that is easy for machine learning researchers to access and interface to their systems. Each patient is identified by an anonymized medical reference number. Within each patient’s directory, one or more sessions are identified, also anonymized to the first of the month in which the sample was taken. These sessions are broken into groupings of tissue taken on that date (in this case, breast tissue). A deidentified patient report stored as a flat text file is also available. Within these slides there are a total of 16,971 total annotated regions with an average of 4.84 annotations per slide. Among those annotations, 8,035 are non-cancerous (normal, background, null, and artifact,) 6,222 are carcinogenic signs (inflammation, nonneoplastic and suspicious,) and 2,714 are cancerous labels (ductal carcinoma in situ and invasive ductal carcinoma in situ.) The individual patients are split up into three sets: train, development, and evaluation. Of the 74 cancerous patients, 20 were allotted for both the development and evaluation sets, while the remain 34 were allotted for train. The remaining 222 patients were split up to preserve the overall distribution of labels within the corpus. This was done in hope of creating control sets for comparable studies. Overall, the development and evaluation sets each have 80 patients, while the training set has 136 patients. In a related component of this project, slides from the Fox Chase Cancer Center (FCCC) Biosample Repository (https://www.foxchase.org/research/facilities/genetic-research-facilities/biosample-repository -facility) are being digitized in addition to slides provided by Temple University Hospital. This data includes 18 different types of tissue including approximately 38.5% urinary tissue and 16.5% gynecological tissue. These slides and the metadata provided with them are already anonymized and include diagnoses in a spreadsheet with sample and patient ID. We plan to release over 13,000 unannotated slides from the FCCC Corpus simultaneously with v1.0.0 of TUDP. Details of this release will also be discussed in this poster. Few digitally annotated databases of pathology samples like TUDP exist due to the extensive data collection and processing required. The breast corpus subset should be released by November 2021. By December 2021 we should also release the unannotated FCCC data. We are currently annotating urinary tract data as well. We expect to release about 5,600 processed TUH slides in this subset. We have an additional 53,000 unprocessed TUH slides digitized. Corpora of this size will stimulate the development of a new generation of deep learning technology. In clinical settings where resources are limited, an assistive diagnoses model could support pathologists’ workload and even help prioritize suspected cancerous cases. ACKNOWLEDGMENTS This material is supported by the National Science Foundation under grants nos. CNS-1726188 and 1925494. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. REFERENCES [1] N. Shawki et al., “The Temple University Digital Pathology Corpus,” in Signal Processing in Medicine and Biology: Emerging Trends in Research and Applications, 1st ed., I. Obeid, I. Selesnick, and J. Picone, Eds. New York City, New York, USA: Springer, 2020, pp. 67 104. https://www.springer.com/gp/book/9783030368432. [2] J. Picone, T. Farkas, I. Obeid, and Y. Persidsky, “MRI: High Performance Digital Pathology Using Big Data and Machine Learning.” Major Research Instrumentation (MRI), Division of Computer and Network Systems, Award No. 1726188, January 1, 2018 – December 31, 2021. https://www. isip.piconepress.com/projects/nsf_dpath/. [3] A. Gulati et al., “Conformer: Convolution-augmented Transformer for Speech Recognition,” in Proceedings of the Annual Conference of the International Speech Communication Association (INTERSPEECH), 2020, pp. 5036-5040. https://doi.org/10.21437/interspeech.2020-3015. [4] C.-J. Wu et al., “Machine Learning at Facebook: Understanding Inference at the Edge,” in Proceedings of the IEEE International Symposium on High Performance Computer Architecture (HPCA), 2019, pp. 331–344. https://ieeexplore.ieee.org/document/8675201. [5] I. Caswell and B. Liang, “Recent Advances in Google Translate,” Google AI Blog: The latest from Google Research, 2020. [Online]. Available: https://ai.googleblog.com/2020/06/recent-advances-in-google-translate.html. [Accessed: 01-Aug-2021]. [6] V. Khalkhali, N. Shawki, V. Shah, M. Golmohammadi, I. Obeid, and J. Picone, “Low Latency Real-Time Seizure Detection Using Transfer Deep Learning,” in Proceedings of the IEEE Signal Processing in Medicine and Biology Symposium (SPMB), 2021, pp. 1 7. https://www.isip. piconepress.com/publications/conference_proceedings/2021/ieee_spmb/eeg_transfer_learning/. [7] J. Picone, T. Farkas, I. Obeid, and Y. Persidsky, “MRI: High Performance Digital Pathology Using Big Data and Machine Learning,” Philadelphia, Pennsylvania, USA, 2020. https://www.isip.piconepress.com/publications/reports/2020/nsf/mri_dpath/. [8] I. Hunt, S. Husain, J. Simons, I. Obeid, and J. Picone, “Recent Advances in the Temple University Digital Pathology Corpus,” in Proceedings of the IEEE Signal Processing in Medicine and Biology Symposium (SPMB), 2019, pp. 1–4. https://ieeexplore.ieee.org/document/9037859. [9] A. P. Martinez, C. Cohen, K. Z. Hanley, and X. (Bill) Li, “Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ,” Arch. Pathol. Lab. Med., vol. 140, no. 7, pp. 686–689, Apr. 2016. https://doi.org/10.5858/arpa.2015-0238-OA.« less
  2. The advent of deep learning algorithms for mobile devices and sensors has led to a dramatic expansion in the availability and number of systems trained on a wide range of machine learning tasks, creating a host of opportunities and challenges in the realm of transfer learning. Currently, most transfer learning methods require some kind of control over the systems learned, either by enforcing constraints dur- ing the source training, or through the use of a joint optimization objective between tasks that requires all data be co-located for training. However, for practical, pri- vacy, or other reasons, in a variety ofmore »applications we may have no control over the individual source task training, nor access to source training samples. Instead we only have access to features pre-trained on such data as the output of “black-boxes.” For such scenarios, we consider the multi-source learning problem of training a classifier using an ensemble of pre-trained neural networks for a set of classes that have not been observed by any of the source networks, and for which we have very few training samples. We show that by using these distributed networks as feature extractors, we can train an effective classifier in a computationally-efficient manner using tools from (nonlinear) maximal correlation analysis. In particular, we develop a method we refer to as maximal correlation weighting (MCW) to build the required target classifier from an appropriate weighting of the feature functions from the source networks. We illustrate the effectiveness of the resulting classi- fier on datasets derived from the CIFAR-100, Stanford Dogs, and Tiny ImageNet datasets, and, in addition, use the methodology to characterize the relative value of different source tasks in learning a target task.« less
  3. Data selection methods, such as active learning and core-set selection, are useful tools for machine learning on large datasets. However, they can be prohibitively expensive to apply in deep learning because they depend on feature representations that need to be learned. In this work, we show that we can greatly improve the computational efficiency by using a small proxy model to perform data selection (e.g., selecting data points to label for active learning). By removing hidden layers from the target model, using smaller architectures, and training for fewer epochs, we create proxies that are an order of magnitude faster tomore »train. Although these small proxy models have higher error rates, we find that they empirically provide useful signals for data selection. We evaluate this “selection via proxy” (SVP) approach on several data selection tasks across five datasets: CIFAR10, CIFAR100, ImageNet, Amazon Review Polarity, and Amazon Review Full. For active learning, applying SVP can give an order of magnitude improvement in data selection runtime (i.e., the time it takes to repeatedly train and select points) without significantly increasing the final error (often within 0.1%). For core-set selection on CIFAR10, proxies that are over 10 faster to train than their larger, more accurate targets can remove up to 50% of the data without harming the final accuracy of the target, leading to a 1:6 end-to-end training time improvement.« less
  4. Many applications of machine learning require a model to make accurate predictions on test examples that are distributionally different from training ones, while task-specific labels are scarce during training. An effective approach to this challenge is to pre-train a model on related tasks where data is abundant, and then fine-tune it on a downstream task of interest. While pre-training has been effective in many language and vision domains, it remains an open question how to effectively use pre-training on graph datasets. In this paper, we develop a new strategy and self-supervised methods for pre-training Graph Neural Networks (GNNs). The keymore »to the success of our strategy is to pre-train an expressive GNN at the level of individual nodes as well as entire graphs so that the GNN can learn useful local and global representations simultaneously. We systematically study pre-training on multiple graph classification datasets. We find that naïve strategies, which pre-train GNNs at the level of either entire graphs or individual nodes, give limited improvement and can even lead to negative transfer on many downstream tasks. In contrast, our strategy avoids negative transfer and improves generalization significantly across downstream tasks, leading up to 9.4% absolute improvements in ROC-AUC over non-pre-trained models and achieving state-of-the-art performance for molecular property prediction and protein function prediction.« less
  5. Salient segmentation is a critical step in biomedical image analysis, aiming to cut out regions that are most interesting to humans. Recently, supervised methods have achieved promising results in biomedical areas, but they depend on annotated training data sets, which requires labor and proficiency in related background knowledge. In contrast, unsupervised learning makes data-driven decisions by obtaining insights directly from the data themselves. In this paper, we propose a completely unsupervised self-aware network based on pre-training and attentional backpropagation for biomedical salient segmentation, named as PUB-SalNet. Firstly, we aggregate a new biomedical data set from several simulated Cellular Electron Cryo-Tomographymore »(CECT) data sets featuring rich salient objects, different SNR settings, and various resolutions, which is called SalSeg-CECT. Based on the SalSeg-CECT data set, we then pre-train a model specially designed for biomedical tasks as a backbone module to initialize network parameters. Next, we present a U-SalNet network to learn to selectively attend to salient objects. It includes two types of attention modules to facilitate learning saliency through global contrast and local similarity. Lastly, we jointly refine the salient regions together with feature representations from U-SalNet, with the parameters updated by self-aware attentional backpropagation. We apply PUB-SalNet for analysis of 2D simulated and real images and achieve state-of-the-art performance on simulated biomedical data sets. Furthermore, our proposed PUB-SalNet can be easily extended to 3D images. The experimental results on the 2d and 3d data sets also demonstrate the generalization ability and robustness of our method.« less